In new book, James Comey blasts untruthful, ‘ego-driven’ Donald Trump

Agencies
April 13, 2018

Washington, Apr 13: Former FBI Director James Comey blasts President Donald Trump as unethical and “untethered to truth” in a sharply critical new book that describes Trump as fixated in the early days of his administration on having the FBI debunk salacious rumors he insisted were untrue but could distress his wife.

In the forthcoming book, Comey compares Trump to a mafia don and calls his leadership of the country “ego driven and about personal loyalty.”

He also reveals new details about his interactions with Trump and his own decision-making in handling the Hillary Clinton email investigation before the 2016 election. He casts Trump as a mobster-like figure who sought to blur the line between law enforcement and politics and tried to pressure him personally regarding his investigation into Russian election interference.

The book adheres closely to Comey’s public testimony and written statements about his contacts with Trump and his growing concern about Trump’s integrity. It also includes strikingly personal jabs at Trump that appear sure to irritate the president.

The 6-foot-8 Comey describes Trump as shorter than he expected with a “too long” tie and “bright white half-moons” under his eyes that he suggests came from tanning goggles. He also says he made a conscious effort to check the president’s hand size, saying it was “smaller than mine but did not seem unusually so.”

The book, “A Higher Loyalty,” is to be released next week. The Associated Press purchased a copy this week. “Donald Trump’s presidency threatens much of what is good in this nation,” Comey writes, calling the administration a “forest fire” that can’t be contained by ethical leaders within the government.

On a more-personal level, Comey describes Trump repeatedly asking him to consider investigating an allegation involving Trump and Russian prostitutes urinating on a bed in a Moscow hotel, in order to prove it was a lie. Trump has strongly denied the allegation, and Comey says that it appeared the president wanted it investigated to reassure his wife, Melania Trump.

Trump fired Comey in May 2017, setting off a scramble at the Justice Department that led to the appointment of Robert Mueller as special counsel overseeing the Russia investigation. Mueller’s probe has expanded to include whether Trump obstructed justice by firing Comey, which the president denies.

Trump has assailed Comey as a “showboat” and a “liar.”

Comey’s account lands at a particularly sensitive moment for Trump and the White House. Officials there describe the president as enraged over a recent FBI raid of his personal lawyer’s home and office, raising the prospect that he could fire Deputy Attorney General Rod Rosenstein, who appointed Mueller, or try to shut down the probe on his own. The Republican National Committee is poised to lead the pushback effort against Comey by launching a website and supplying surrogates with talking points that question his credibility.

Trump has said he fired Comey because of his handling of the FBI’s investigation into Clinton’s email practices. Trump used the investigation as a cudgel in the campaign and repeatedly said Clinton should be jailed for using a personal email system while serving as secretary of state. Democrats, on the other hand, have accused Comey of politicizing the investigation, and Clinton herself has said it hurt her election prospects.

Comey writes that he regrets his approach and some of the wording he used in his July 2016 press conference in which he announced the decision not to prosecute Clinton. But he says he believes he did the right thing by going before the cameras and making his statement, noting that the Justice Department had done so in other high profile cases.

Every person on the investigative team, Comey writes, found that there was no prosecutable case against Clinton and that the FBI didn’t find that she lied under its questioning.

He also reveals new details about how the government had unverified classified information that he believes could have been used to cast doubt on Attorney General Loretta Lynch’s independence in the Clinton probe. While Comey does not outline the details of the information — and says he didn’t see indications of Lynch inappropriately influencing the investigation — he says it worried him that the material could be used to attack the integrity of the probe and the FBI’s independence.

Comey’s book will be heavily scrutinized by the president’s legal team looking for any inconsistencies between it and his public testimony, under oath, before Congress. They will be looking to impeach Comey’s credibility as a key witness in Mueller’s obstruction investigation, which the president has cast as a political motivated witch hunt.

The former FBI director provides new details of his firing. He writes that then-Homeland Security Secretary John Kelly — now Trump’s chief of staff — offered to quit out of disgust at how Comey was dismissed. Kelly has been increasingly marginalized in the White House and the president has mused to confidants about firing him.

Comey also writes extensively about his first meeting with Trump after the election, a briefing in January 2017 at Trump Tower in New York City. Others in the meeting included Vice President Mike Pence, Trump’s first chief of staff, Reince Priebus, Michael Flynn, who would become national security adviser, and incoming press secretary, Sean Spicer. Comey was also joined by NSA Director Mike Rogers, CIA Director John Brennan and Director of National Intelligence James Clapper.

After Clapper briefed the team on the intelligence community’s findings of Russian election interference, Comey said he was taken aback by what the Trump team didn’t ask.

“They were about to lead a country that had been attacked by a foreign adversary, yet they had no questions about what the future Russian threat might be,” Comey writes. Instead, they launched into a strategy session about how to “spin what we’d just told them” for the public.

Comey says he had flashbacks to his time investigating the Italian Mafia as a federal prosecutor in Manhattan, thinking that Trump “was trying to make us all part of the same family.”

“For my entire career, intelligence was a thing of mine and political spin a thing of yours. Team Trump wanted to change that,” he writes.

Comey then describes talking to Trump one-on-one after the broader meeting.

He says he described the allegations about Russian prostitutes. He writes that he told Trump about the dossier because it was the FBI’s responsibility to protect the presidency from coercion related to harmful allegations, whether supported or not. Comey said he left out one detail involving an allegation that the prostitutes had urinated on a bed once used by the Obamas.

Trump raised the subject again a week later, after the dossier had been made public. He then told Comey, the director writes, that he had not stayed in the hotel and that the most salacious charge could not have been true because, Trump said, “I’m a germaphobe. There’s no way I would let people pee on each other around me. No way.”

Comey writes that Trump raised the issue again, unprompted, during their one-on-one dinner at the White House and it bothered the president that there might be even “a one percent chance” his wife might think it was true.

Comey then registers surprise, writing that he thought to himself “why his wife would think there was any chance, even a small one, that he had been with prostitutes urinating on each other in a Moscow hotel room.”

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 22,2020

Washington, May 22: The deadly coronavirus came from China and the US is not going to take it lightly, American President Donald Trump said on Thursday.

"It came from China. We are not happy about it. We just signed a trade deal, the ink wasn't dry and all of the sudden this floated in. We are not going to take it lightly,” Trump said participating in a Listening Session with African-American Leaders in Michigan.

Trump in the last several weeks has been very critical of China's inability to control the spread of the novel coronavirus within its territory. By Thursday more than 94,000 Americans have died due to the coronavirus and over 1.6 million have tested positive.

He has so far not given any indication of the steps that he is contemplating taking against China.

Meanwhile, pressure is building on his administration, mainly from the Republican lawmakers on this.

On Thursday, Senators Ted Cruz and Rick Scott, along Mike Braun, Marsha Blackburn, Joni Ernst, Martha McSally and Tom Cotton, introduced the COVID-19 Vaccine Protection Act to prevent the Chinese Communist Party from stealing or sabotaging American COVID-19 vaccine research.

The bill requires a thorough national security evaluation and clearance by the Department of Homeland Security, the Department of State, and the Federal Bureau of Investigation of all Chinese student visa holders taking part in activities related to COVID-19 vaccine research.

"The same Chinese Communist Party that covered up the coronavirus outbreak also routinely engages in state sponsored theft of intellectual property," Cruz said. "We cannot allow China to steal or interfere with American research and development of a vaccine,” he added.

"Communist China is responsible for the coronavirus pandemic, and their lies and misinformation cost American lives," Scott said.

"We cannot let Communist China off the hook for this, and we absolutely cannot allow Communist China to steal or sabotage any American research efforts related to the Coronavirus vaccine. The COVID-19 Vaccine Protection Act protects American efforts to create a vaccine as we work to end this pandemic," he added.

The COVID-19 Vaccine Protection Act, among others requires an enhanced vetting of nationals of the Chinese nationals in the US as nonimmigrants under F, J, or M student visas to determine if any student visa holders are a national security threat.

Once the review is complete, authorizes Department of Homeland Secretary, in consultation with other agencies, to continuously monitor all nonimmigrant student visa holders (F, M, J) who are Chinese nationals while in the US and are engaged in, or have access to, the research of any potential COVID-19 vaccine or COVID-19 related material.

Republican Whip and Ranking Member of the Select Subcommittee on the Coronavirus Crisis Steve Scalise alleged that China lied to the world on coronavirus.

"During a critical period in December and January, China withheld evidence of the virus: evidence that confirmed human to human transmission of the virus, evidence of the extent of the spread. China refused entry of American and other medical experts from around the world for weeks,” he said.

“And during this time, China hoarded medical supplies like masks, gowns, and other life-saving PPE. Chinese exports of surgical masks, gowns, and gloves were stifled by the Chinese Communist Party during this period. China knew the danger posed by the virus and while they hid the truth, they used the time to stock up on vital medical supplies,” Scalise said.

“While Chinese authorities limited domestic flights from Wuhan to other Chinese cities like Beijing and Shanghai, China's government urged international carriers to maintain their flight schedules — seeding the virus throughout the rest of the world,” he alleged.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
March 28,2020

Canadian researchers are developing a DNA vaccine for SARS-CoV-2, the coronavirus that causes COVID-19 and has currently infected nearly 5,00,000 people worldwide and crippled the global economy.

Entos Pharmaceuticals, a health-care biotechnology company headed by a University of Alberta researchers, develop new therapeutic compounds using the company's proprietary drug-delivery platform and has begun manufacturing vaccine candidates against the novel coronavirus.

"Given the urgency of the situation, we can have a lead candidate vaccine within two months. Once we have that it's a race to get it into clinical trials," said John Lewis, CEO of Entos and a Professor at the University of Alberta in Canada.

Lewis said in comparison to a traditional vaccine, DNA-based vaccines hold several advantages.

Nucleic acids are introduced directly into the patient's own cells, causing them to make pieces of the virus--tricking the immune system into mounting a response without the full virus actually being present, the researcher said.

According to the company, the approach is recognised as being easier to move into large-scale manufacturing, offers improved vaccine stability and works without needing an infectious agent.

In the current absence of a vaccine for COVID-19, several companies around the world are mounting efforts to begin similar work.

The first clinical trial using a DNA-based vaccine developed by Moderna Inc.in the US on March 13.

Their approach allows for antibodies to be made in the human trial volunteers against a specific protein on the surface of the coronavirus that lets the virus enter human cells.

The hope is that the antibodies will stop the interaction.

Though this approach is designed to be effective against COVID-19 specifically, Lewis said Entos is taking a different tack.

The company plans to use plasmid DNA to amplify the production of key coronavirus surface and structural proteins with each injection, with an eye to the bigger picture.

"Many of the structural proteins in the virus are pretty well conserved across all the coronaviruses, including SARS and MERS," said Lewis.

"We're hoping that if we express more of the structural proteins that are common to most coronaviruses, we can inhibit the current COVID-19, and also potentially protect against all coronaviruses both past and future," Lewis added.

To move the project forward quickly, the company is seeking financial support from both provincial and federal levels of government.

"We have the opportunity to save a lot of lives, and I think it's really upon us and governments to find solutions for that," Lewis said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 9,2020

Washington, Jun 9: When epidemiologists talked about "flattening the curve," they probably didn't mean it this way: the US hit its peak coronavirus caseload in April, but since that time the graph has been on a seemingly unending plateau.

That's unlike several other hard-hit countries which have successfully pushed down their numbers of new cases, including Spain and Italy, which now have bell-shaped curves.

Experts say the prolonged nature of the US epidemic is the result of the cumulative impact of regional outbreaks, as the virus that started out primarily on the coasts and in major cities moves inward.

Layered on top of that are the effects of lifting lockdowns in parts of the country that are experiencing rising cases, as well as a lapse in compliance with social distancing guidelines because of economic hardship, and in some cases a belief that the threat is overstated.

"The US is a large country both in geography and population, and the virus is at very different stages in different parts of the country," Tom Frieden, a former director of the Centers for Disease Control and Prevention told AFP.

The US saw more than 35,000 new cases for several days in April. While that figure has declined, it has still been exceeding 20,000 regularly in recent days.

By contrast, Italy was regularly hitting more than 5,000 cases per day in March but is currently experiencing figures in the low hundreds.

"We did not act quickly and robustly enough to stop the virus spreading initially, and data indicate that it travelled from initial hotspots along major transport routes into other urban and rural areas," added Frieden, now CEO of the non-profit Resolve to Save Lives.

To wit: the East Coast states of New York, New Jersey and Massachusetts accounted for about 50 percent of all cases until about a month or so ago -- but now the geographic footprint of the US epidemic has shifted to the Midwest and southeast, including Florida.

Another key problem, said Jennifer Nuzzo, an epidemiologist at Johns Hopkins, is that the United States is still not doing enough testing, contact tracing and isolation.

After coming late to the testing party -- for reasons ranging from technical issues to regulatory hurdles -- the US has now conducted more COVID-19 tests than any other country.

It even has one of the highest per capita rates per country of 62 per 1,000 people, according to the website ourworldindata.org -- better than Germany (52 per 1,000) and South Korea (20 per 1,000).

But according to Nuzzo, these numbers are misleading, because "the amount of testing that a country should do should be scaled to the size of its epidemic.

"The United States has the largest epidemic in the world so obviously we need to do a lot more testing than any other country."

For Johns Hopkins, the more important metric is the positivity rate -- that is, out of all tests conducted, how many came back positive for COVID-19.

As of June 7, the United States had an average daily positivity rate of 14 percent, well above the World Health Organization guideline of 5 percent over two weeks before social distancing guidelines should be relaxed.

By contrast, Germany, which has tested far fewer people in relation to its population, has a positivity rate of 5 percent.

Even if testing were scaled up, carrying out tests in of itself does very little good without the next steps -- finding out who was exposed and then asking them to isolate.

Here also, too many US states are lagging woefully behind.

Texas, which is experiencing a surge in cases after relaxing its lockdown, is a case in point. The state targeted hiring a modest 4,000 tracers by June, but according to local reports is still more than a thousand shy of even that goal.

Opt-in app based efforts have also been slow to get off the ground.

Then there is the fact that some people are growing tired of lockdowns, while others don't have the economic luxury of being able to stay home for prolonged periods.

The government sent some 160 million Americans a single stimulus check of up to $1,200 back in April but it's not clear whether more will be forthcoming.

Still others, particularly in so-called red states under Republican leadership, have chafed under restrictions and mask-wearing guidelines that they see as an affront to their personal freedom.

"The US is kind of on the extreme of the individual liberty side," Sten Vermund, dean of the Yale School of Public Health, told AFP.

Part of this has to do with mixed messaging from Republican leaders, including President Donald Trump, said Nuzzo.

"We have had at the highest political level an assertion that this is a situation that's been overblown, and that maybe certain protective behaviors are not necessary," she said.

More recently, tens of thousands of people across the country have taken to the streets to protest the killing on an unarmed black man by police, risking coronavirus infection to demonstrate against the public health threat of racialized state violence.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.